ResearcherSir Run Run Shaw HospitalActive in the last 2 years

Tianshu Pang

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5112728960. Sources: OpenAlex.

Their work

Papers: 3
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 11

Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper

Papers 3

Diagnostic plasma small extracellular vesicles miRNA signatures for pancreatic cancer using machine learning methods. Co-author DOI 10.1016/j.tranon.2023.101847 ↗
ZC3H13-mediated N6-methyladenosine modification of PHF10 is impaired by fisetin which inhibits the DNA damage response in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2022.01.013 ↗
A novel scoring system to analyze combined effect of lifestyle factors on pancreatic cancer risk: a retrospective case-control study. Co-author DOI 10.1038/s41598-017-13182-w ↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Liping Cao · 3 shared papers, 2017–2024 · strength 0.45
Chaolei Zhang · 2 shared papers, 2022–2024 · strength 0.37
- Paper Diagnostic plasma small extracellular vesicles miRNA signatures for pancreatic cancer using machine learning methods. DOI 10.1016/j.tranon.2023.101847 ↗
- Paper ZC3H13-mediated N6-methyladenosine modification of PHF10 is impaired by fisetin which inhibits the DNA damage response … DOI 10.1016/j.canlet.2022.01.013 ↗
Guoping Ding · 2 shared papers, 2017–2022 · strength 0.23
- Paper ZC3H13-mediated N6-methyladenosine modification of PHF10 is impaired by fisetin which inhibits the DNA damage response … DOI 10.1016/j.canlet.2022.01.013 ↗
- Paper A novel scoring system to analyze combined effect of lifestyle factors on pancreatic cancer risk: a retrospective case-… DOI 10.1038/s41598-017-13182-w ↗
Shengnan Jia · 1 shared paper, 2024 · strength 0.22
- Paper Diagnostic plasma small extracellular vesicles miRNA signatures for pancreatic cancer using machine learning methods. DOI 10.1016/j.tranon.2023.101847 ↗
Tao Shen · 1 shared paper, 2024 · strength 0.22
- Paper Diagnostic plasma small extracellular vesicles miRNA signatures for pancreatic cancer using machine learning methods. DOI 10.1016/j.tranon.2023.101847 ↗
Xiaofan Pu · 1 shared paper, 2024 · strength 0.22
- Paper Diagnostic plasma small extracellular vesicles miRNA signatures for pancreatic cancer using machine learning methods. DOI 10.1016/j.tranon.2023.101847 ↗
Chaojie Huang · 1 shared paper, 2022 · strength 0.15
- Paper ZC3H13-mediated N6-methyladenosine modification of PHF10 is impaired by fisetin which inhibits the DNA damage response … DOI 10.1016/j.canlet.2022.01.013 ↗
Liangjing Zhou · 1 shared paper, 2022 · strength 0.15
- Paper ZC3H13-mediated N6-methyladenosine modification of PHF10 is impaired by fisetin which inhibits the DNA damage response … DOI 10.1016/j.canlet.2022.01.013 ↗
Shengnan Jia · 1 shared paper, 2022 · strength 0.15
- Paper ZC3H13-mediated N6-methyladenosine modification of PHF10 is impaired by fisetin which inhibits the DNA damage response … DOI 10.1016/j.canlet.2022.01.013 ↗
Guixing Jiang · 1 shared paper, 2017 · strength 0.08
- Paper A novel scoring system to analyze combined effect of lifestyle factors on pancreatic cancer risk: a retrospective case-… DOI 10.1038/s41598-017-13182-w ↗
Zhengrong Wu · 1 shared paper, 2017 · strength 0.08
- Paper A novel scoring system to analyze combined effect of lifestyle factors on pancreatic cancer risk: a retrospective case-… DOI 10.1038/s41598-017-13182-w ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.